Summary. Recent findings suggest a possible role of diet in age-related cognitive decline, and cognitive impairment of both degenerative (Alzheimer's disease, AD) or vascular origin. In particular, in an older population of Southern Italy with a typical Mediterranean diet, high monounsaturated fatty acids energy intake appeared to be associated with a high protection against cognitive decline. In addition, dietary fat and energy in older people seem to be risk factors, while fish consumption and cereals are found to reduce the prevalence of AD in the European and North American countries. Moreover, foods with large amounts of aluminium-containing additives or aluminium from drinking water may affect the risk of developing AD. Vitamin deficiencies, especially vitamin B6, B12 and folates, and antioxidant deficiencies (vitamins E and C) could also influence the memory capabilities and have an effect on cognitive decline. Dietary anti-oxidants and supplements and specific macronutrients of the diet may act synergistically with other protective factors opening new possibilities of intervention for cognitive decline.
Introduction
Cognitive impairment is a major component of dementing syndromes and influences the individual's ability to function independently. Due to ageing of the population, the prevalence of cognitive impairment is expected to increase, and establishing the diagnosis at the preclinical phase of dementia would be likely to increase the efficacy of treatment.
Mild cognitive impairment (MCI) is, at present, the most widely used term to indicate nondemented aged persons with a mild memory or cognitive impairment that cannot be accounted for any recognized medical or psychiatric condition (Petersen et al., 1999) . Different diagnostic criteria have been proposed to distinguish individuals with mild cognitive disorders associated with ageing from non affected individuals, and one of the best established classification is age-associated memory impairment (AAMI) (Crook et al., 1986) . The terms <<age-related cognitive decline>> (ARCD) (American Psychiatric Association, 1994) and <<ageing-associated cognitive decline>> (AACD) (Levy, 1994) have been recently proposed to indicate an objective decline in cognitive functioning associated to the ageing process but within normal limits given the person's age. Whether ARCD is expression of a normal ageing process, or represents a distinct clinical entity, or, eventually, is a continuum with dementia is still difficult to establish (Brayne and Calloway, 1988) . In fact, while MCI is assumed to be pathology-based and therefore amenable to interventions, ARCD and AACD are generally considered nonprogressive, a phenomenon of normal ageing. Furthermore, MCI may be a prodromal phase of dementia, with estimates of 12% of MCI patients developing dementia in 1 year (Petersen et al., 1999 (Petersen et al., , 2001 ), 20% over 3 years (Wolf et al., 1998) , and rates of progression to dementia of 19.9% at 5 years in subjects classified 0.5/uncertain dementia with Clinical Dementia Rating scale (Morris, 1993) . Identification of possible risk factors for conversion of MCI to dementia may be crucial for prevention. The causes of cognitive decline are, at present, unknown; some studies have suggested that it may be prevented (Capurso et al., 1997; Solfrizzi et al., 1999) , but the role of the diet in cognitive decline has not been extensively investigated.
In contrast to MCI, a diagnosis of dementia is made when cognitive impairment is greater than that found in normal ageing, affects two or more cognitive domains, and the person's ability to function (American Psychiatric Association, 1994) . Current nosology proposes that the two most common causes are Alzheimer's disease (AD) and Vascular dementia (VaD), with respective frequencies of 70% and 15% of all dementias (Whitehouse et al., 1997) . AD can be diagnosed with certainty at autopsy, but it can also be diagnosed with reliable clinical criteria established in 1984 by the National Institute for Neurological and Communicative Disorders and Stroke/ Alzheimer's Disease and Related Disorders Association criteria (NINCDS/ ADRDA criteria) (McKhann et al., 1984) . VaD, on the other hand, is more problematic as a nosologic entity. In fact, while criteria for AD have remained stable for 17 years, multiple criteria for VaD have been proposed in this same period: the State of California Alzheimer's Disease Diagnostic and Treatment Centers (ADDTC) criteria (Chui et al., 1992) ; the National Institute for Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINDS-AIREN) criteria (Roman et al., 1993) , and the DSM IV criteria (American Psychiatric Association, 1994) . The diagnosis of certainty for VaD also relies on pathological findings, but the pathological diagnosis usually does not confirm the clinical diagnosis (Gold et al., 2002) . In fact, the sensivity of NINDS-AIREN criteria for probable VaD is unexpectedly low (55%), and these criteria were able to exclude patients with AD but they failed to diagnose one third of the neuropathologically confirmed cases of VaD.
Finally, there is no doubt that depression can be associated with cognitive impairment (Jorm et al., 1991) , but there are various hypotheses that might explain this relationship. In fact, there is sufficient evidence to support the possibility that depression is a risk factor for dementia and cognitive decline (Jorm et al., 2000) . Further work is needed to confirm if depression may be a prodrome of dementia (Reding et al., 1985) , or could play a causal role in dementia, as a source of hippocampal damage through a glucorticoid cascade (Sapolsky, 1992) .
The aim of this presentation is to examine in depth the possible role of micro-and macronutrients in modulating the risk of age-related changes of cognitive function, and the cognitive decline of degenerative (Alzheimer's disease, AD) or vascular origin (vascular dementia, VaD). We reviewed epidemiological studies from international literature through keyword and author searches of Medline from January 1983 to March 2002.
Dietary micro-and macronutrients in cognitive decline
Low serum levels of micronutrients (B 1 , B 2 , B 6 , B 12 , C vitamins, and folate) have been quite frequently described in older people and significantly associated with cognitive impairment in epidemiological studies (Goodwin et al., 1983; Perrig et al., 1997) . Goodwin et al. (1993) found a correlation between memory test scores and plasma levels of ascorbic acid (vitamin C), without adjustment for education. Perrig et al. (1997) showed that higher ascorbic acid and beta-carotene plasma levels were associated with increased memory performance in older people, in which were measured twice, 22 years prior and concurrently with cognitive test administration. Furthermore, decreasing serum levels of vitamin E were associated with poor memory performance in older people (Perkins et al., 1999) . More recently, ascorbic acid seemed to be protective against cognitive decline in a cohort study in which vitamin C intake was measured at baseline, and cognitive function was assessed 4 years later (Paleologos et al., 1998) . Moreover, other evidence supports cognitive effects of caloric intake or serum levels of folate, vitamins A, E, C, B12, and B6 (Goodwin et al., 1983; Tucker et al.,1990; Riggs et al., 1996; La Rue et al., 1997) . Recent data suggest a relationship among performance in neuropsychological tests and intake of zinc, vitamin E, and C in older subjects with "successful ageing" (Ortega et al., 1997) . The possible role of past intake of anti-oxidant supplements and cognitive function was examined in the cohort of the Honolulu Heart program [HHP] -Honolulu-Asia Aging Study [HAAS] , in 3,385 older Japanese subjects, in which use of either vitamin E or C supplements alone was associated significantly with better cognitive test performance after 3 and 5 years, and use of both vitamin E and C together had borderline significance. The apparently contradictory results of these studies could be in part explained by different end-points (evaluation of functional status) or utilization of various cognitive measures with tools assessing mental status or single cognitive functions (memory, abstraction, or visuo-spatial abilities). In conclusion, cognitive disorders may derive from severe vitamin deficiences, with some improvement in cognitive performance after vitamin supplementation in these vitamin-deficient patients (Martin et al., 1992) ; but, at present, in healthy older people who consume normal amounts of vitamins, there is only a preliminary evidence of a preventive role of vitamin supplementation on cognitive decline (Deijen et al., 1992) . Severe vitamin deficiences are rarely observed and do not explain the epidemiological observations on an association with vitamin intake or plasma levels and cognitive performance where plasma vitamin levels were mostly within normal limits. In fact, these studies simply compare low plasma values or low intake of vitamins vs. high plasma values or high intake. Furthermore, higher intake of antioxidants may have a protective effect on cognitive function, but one important question is whether this effect could be obtained by increasing the dietary amounts of fresh fruits and vegetables. Animal studies suggested that diets high in antioxidant-rich foods, such as spinach, strawberries, and blueberries, rich in anthocyanins and other flavonoids, may be beneficial in slowing age-related cognitive decline (Joseph et al., 1999) . These findings were confirmed by the Rotterdam Study, in which a cross-sectional inverse relation of beta-carotene to cognitive impairment (MMSE Յ25) was found (Jama et al., 1996) . But in the Zutphen Elderly Study there was no association of anti-oxidants to either cognitive impairment (cross-sectional analysis) or cognitive decline (longitudinal analysis) (Kalmijn et al., 1997a) . The mechanisms involved in these beneficial effects of fresh fruit and vegetable intakes are at present largely unknown, but probably flavonoids and other polyphenolic compounds of these foods may have potent antiinflammatory and membrane fluidising properties that, acting synergistically with their antioxidant activity, could explain these positive effects.
Concerning the role of dietary macronutrient intake in cognitive decline, very few data are available. In the Italian Longitudinal Study on Aging, we investigated the relationships between dietary macronutrient intakes and agerelated changes in cognitive functions in Southern Italy, a region with a typical Mediterranean dietary pattern (Capurso et al., 1997; Solfrizzi et al., 1999) (Table 1) . This model included diets consumed in olive-producing Mediterranean regions. The trivial term "Mediterranean diet" is used to refer to dietary patterns similar to those of Crete in the early 1960s and other regions in the Mediterranean where olive oil is a major fat source. In our study, monounsaturated fatty acids (MUFA) intake was significantly associated with a reduction in odds ratio of global cognitive functions and selective attention (over 2400 kJ: odds ratio: 0.69 and 0.99, respectively). Furthermore, the effect of education on the odds of having a cognitive impairment decreased exponentially in MUFA energy intakes. These findings appear to be consistent with other studies, and indicate an association between dietary intakes with cognitive functions. In fact, in a recent study, the association between functional variables and alcohol intake was probably related to a better health status of moderate alcohol consumers (Pradignac et al., 1995) (Table 1) . In another recent longitudinal study on older community residents, a significant association between protein intakes and cognitive performances was found (La Rue et al., 1997) (Table 1) . Furthermore, noninstitutionalized older subjects with lower intake of MUFA, saturated fatty acids (SFA), and cholesterol, and higher intakes of total food, fresh fruit, carbohydrate, thiamine, folate, vitamin C, and minerals (iron and zinc) had the best performance in cognitive tests (Ortega et al., 1997) (Table 1) . Therefore the observed association between protein intake and cognitive performance could be due to protein intake, but also to zinc, meat being one of the most important sources of zinc. Ortega's study supported this interpretation, while apparently conflicting findings on MUFA intake could be partially due to some methodological differences in food-frequency questionnaires and selection of participants. Socio-economic and educational factors, determining the choice of nutrients in different populations and countries, might influence the strenght of association of various nutrients and cognitive function. Finally, caffeine may improve cognitive performance. Higher levels of coffee consumption were associated with improved cognitive performance in older British people in a preliminary study (Jarvis, 1993) . Older people appeared to be more susceptible to the performance-improving effects of caffeine than were younger people. Similar but weaker associations were found for tea consumption. These associations have not yet been studied in clinical trials. The mechanisms by which elevated MUFA intake could be protective against cognitive decline in healthy older people are, at present, unknown. This effect could be related to the role of dietary fatty acids in maintaining the structural integrity of neuronal membranes, determining the fluidity of synaptosomal membranes and thereby regulating neuronal transmission (Jones et al., 1997) . Moreover, fatty acid composition of neuronal membranes demonstrated an increase in MUFA content and a decrease in PUFA content in advancing age (Lopez et al., 1995) . In our elderly subjects, which fulfilled a Mediterranean dietary pattern, total fat is 29% of energy, with large consumption of olive oil (46 g/d), a MUFA energy intake of 17.6% of total energy, 85% of which derived from olive oil, and a SFA intake of only 6% (Solfrizzi et al., 1999) . In a series of studies, rats, administered diets high in SFA or PUFA, were impaired on various tests of learning and memory (Greenwood and Winocur, 1996; Winocur and Greenwood, 1999) . These findings are consistent with another recent prospective study in which high PUFA intake was positively associated with cognitive impairment in elderly subjects, while high fish consumption tended to be inversely associated with cognitive impairment (Kalmijn et al., 1997a) (Table 1) . Therefore, high MUFA intake may be a marker for other dietary factors responsible for protection against cognitive disorders, i.e. the great amount of tocopherol and polyphenols, the antioxidant compounds of olive oil, and the low intake of SFA, that, in our elderly population, could act synergistically in improving cognitive performance.
Dietary micro-and macronutrients in dementia
Several studies have extensively investigated the causes of dementia, both primary degenerative dementia (AD) or VaD. It is well established that vascular risk factors are the main cause of cerebrovascular disease and the presence of these factors has traditionally been used to make clinical differentiation between AD and VaD. However, evidence of overlap between degenerative and vascular disorders is emerging from pathologic and epidemiologic studies, in which an association between AD and vascular risk factors such as arterial hypertension (Skoog et al., 1996) , diabetes mellitus (Ott et al., 1999) , atrial fibrillation , and generalized atherosclerosis were found. Furthermore, dietary patterns and preferences for different foods are similar in patients with VaD or AD. In fact, in a study in which these two groups of patients were compared with elderly normal controls, was found that AD patients had a greater preference than normal controls for sugar and sweet foods, but did not significantly differ in preference for those high in complex carbohydrates and protein (Mungas et al., 1990) . This pattern of food preference does not seem to be specific to AD because a similar pattern was present in VaD patients. Furthermore, the craving for sweet food could be only a form of disinhibited behaviour associated with dementia, or might have a more specific biological substrate, increasing demand of brain serotonin in demented patients. Complex carbohydrates should increase availability of tryptophan and facilitate serotonin synthesis, whereas high protein foods might inhibit these processes (Wurtman, 1988) . Furthermore, there is increasing evidence that a disturbed glucose metabolism, oxidative stress and formation of advanced glycation endproducts and their interaction in a vicious cycle are also important for the onset and progression of AD. In fact, a recent hypothesis suggest that sporadic late-onset AD is caused by non-insulin dependent diabetes mellitus which is confined to the brain (Hoyer, 1998 (Hoyer, , 2002 ). This hypothesis is based on recent findings who clearly demonstrate a perturbation of the neuronal insulin/ insulin receptor signal transduction pathway which is considered to be the pathobiochemical basis for the drastic reduction in glucose/energy metabolism in AD brain (Frolich et al., 1998) . The desensitization of the neuronal insulin receptor along with a reduction in brain insulin concentration is assumed to induce a cascade-like process of disturbances including cellular glucose, acetylcholine, cholesterol, and ATP associated with abnormalities in membrane pathology and the formation of both amyloidogenic derivatives and hyperphosphorylated tau protein (Munch et al., 1998) .
Protective effect of some dietary micronutrients with antioxidant properties seems to be better defined in VaD than in AD. In fact, in the cohort of the HHP-HAAS, combined vitamin E and C supplement use was associated with a reduction of 88% in the frequency of subsequent VaD in Japanese subjects. They were also protect against mixed/other types of dementia, while no protective effect was found in AD (Masaki et al., 2000) . Moreover, fresh fruits and vegetables could also have protective effects against stroke (Gilman et al., 1995) and subsequently against VaD. In fact, in a recent study, the risk of poststroke dementia is high (28.5% in a 3-year follow-up, with most of patients during the first 6 months after stroke), with about one-third of patients meeting the criteria for AD and two-thirds meeting the criteria for VaD (Henon et al., 2001) .
High plasma homocysteine levels can be largely attributed to inadequate B vitamin status (Selhub and Miller, 1992) , and are associated with stroke and thrombosis (Boushey et al., 1995) . Silent brain infarcts and white matter lesions are both associated with an increased risk of stroke and dementia. In fact, in cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia (Clarke et al., 1998) . The recent findings of the Rotterdam Scan Study, a population-based study of 1,077 people aged 60 to 90 years who had cerebral magnetic resonance imaging, suggest that total homocysteine levels are associated with silent brain infarcts and white matter lesions independent of each other and of other cardiovascular risk factors (Vermeer et al., 2002) . Furthermore, in a recent study on a sample of 1,092 subjects without dementia from the Framingham Study was examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. With a plasma homocysteine level greater than 14 micromol per liter, the risk of AD nearly doubled. An increased plasma homocysteine level seems to be a strong, independent risk factor for the development of dementia and AD, suggesting that the elevated homocysteine levels precede the onset of dementia, not resulting from dementia-related nutritional and vitamin deficiencies (Seshadri et al., 2002) . The underlying mechanism is unknown but recent data suggest that impaired one-carbon metabolism resulting from folic acid deficiency and high homocysteine levels promotes accumulation of DNA damage and sensitizes neurons to amyloid -peptide toxicity (Kruman et al., 2002) .
A recent study suggested that elevated intake of lipids and saturated fat increased risk for dementia with cerebrovascular component (Kalmijn et al., 1997b) (Table 2) . A prospective 12-year follow-up study of 859 healthy subjects aged 50-79 years provided some preliminary evidence that dietary potassium may be vaso-protective; there was a 40% reduction in stroke mortality with a 10 mmol per day increase in dietary potassium intake (Khaw and Barret-Connor, 1987) . The first National Health and Nutrition Examination Survey (NHANES I) Epidemiologic Follow-Up Study, in a very recent 19-year follow-up study, confirmed that low dietary potassium intake is associated with an increased risk of stroke (Bazzano et al., 2001) .
One of the most interesting findings of a recent study on VaD risk factors conducted on the cohort of the HAAS was the protective effect of a Western diet against the development of VaD (Ross et al., 1999) . A traditional Western diet is high in animal fat and protein and low in complex carbohydrates, compared to the traditional Japanese diet which is high in complex carbohydrates and low in animal fat and protein (Table 2) . This is an interesting approach in which dietary patterns and not only single micro-or macronutrients are considered in explaining the possible role of diet in cognitive decline. The mechanism by which an oriental diet leads to VaD remains speculative. The higher risk of stroke could probably be referred to the lower intake of animal fat and protein. As these findings do not allow analysis of separate nutrients, a hypothesis could be that more fat intake may stabilize the integrity of smaller intracranial arterioles, while the quantity and quality of dietary protein may affect small vessel pathology.
Dietary patterns and single nutrients in Alzheimer's disease
Recent findings showing that older African-Americans (Hendrie et al., 1995) and Japanese living in the United States (White et al., 1996) have much higher prevalence of AD (6.24% and 4.1%, respectively) than those still living in their ethnic homelands (Ͻ2%) suggested that the prevalence of AD is more strongly influenced by diet and nutrition, environment, and/or lifestyle, than by genetics. However, the simple comparison of prevalence data might be misleading, since there is a large difference in selective survival and other cultural effects. A more valuable comparison would be that of the overall dementia rate between different countries, culturally adjusted. In a recent cross-sectional study on AD, regression analyses have been performed in the 65ϩ age population of 11 countries obtained from 18 community-wide studies versus components of the national diets (Grant, 1999) . The primary finding is that fat and total caloric supply have the highest correlations with AD prevalence rates. In addition, fish consumption is found to reduce the prevalence of AD in the European and North American countries. These ecological evidences are in agreement with various recent epidemiologic studies (Grant, 1999) . In fact, the finding that total dietary fat is a high risk factor for the development of AD has been reported in the Rotterdam Study, although not at a statistically-significant level. In the same study fish consumption was confirmed to reduce AD risk and linoleic acid was inversely correlated with AD (Kalmijn et al., 1997b) . A significant inverse correlation was found between the fraction of calories derived from cereals and AD prevalence (Grant, 1999) . While whole grains have antioxidant vitamins and minerals, it is not clear whether the cereals generally consumed are whole grains. Therefore, this relationship could be due to the fact that countries with low fat supply have high cereals supply, rather than to a direct therapeutic effect of the cereals. Finally, red wine, another component of Mediterranean diet, has been investigated in the PAQUID study, in which the relative risks for dementia and AD among the 318 subjects of this cohort who drank three or four glasses of wine each day in comparison with the 971 total abstainers were 0.21 and 0.25, respectively. Among the 922 older subjects who drank no more than one or two glasses of wine each day respect to the abstainers the relative risk for AD was reduced significantly (0.55) (Orgogozo et al., 1997) . More recently, the relation between alcohol consumption and risk of dementia (AD, VaD, or other dementia) was investigated in the Rotterdam Study. The findings of this study, with an average follow-up of 6.0 years, suggested that light-to-moderate alcohol consumption is associated with a reduced risk of dementia in individuals aged 55 years or older; this effect seems to be unchanged by the source of alcohol (Ruitenberg et al., 2002) (Table 2) . Mediterranean diet could be therefore an interesting model to further study the association between dietary patterns and cognitive functioning, given the suggested role of many components of this diet (MUFA, cereals, and red wine) in contrasting cognitive impairment. Many lines of evidence have focused on the importance of oxidative stress mechanisms and free radical damage in AD pathogenesis. Many free radical scavengers are present in food, particularly in fresh fruit and vegetables (e.g., as carotenoids and flavonoids). Regular consumption of antioxidants in the diet may have a beneficial effect in humans (Gale et al., 1996) . Furthermore, data on the relationship between vegetable and fresh fruit consumption and risk of degenerative disease demonstrated that other nutrients in addition to the well-known antioxidants may play important roles in the central nervous system (Martin et al., 2000) . The possibility of the therapeutic use of antioxidants and free radical scavengers (e.g., vitamin E, Gingko Biloba extract EGb 761, melatonin, flavonoids, and carotenoids) to reduce the risk or slow the progression of the disease has been suggested. The only epidemiological study conducted to support the beneficial effects of dietary antioxidants in AD is the PAQUID study, in which the intake of antioxidant flavonoids is inversely related to the risk of incident dementia (Table 2 ). Findings of a large multicenter trial support this concept, showing that vitamin E and/or selegiline hydrochloride may slow the progression of AD (Sano et al., 1997) . These results suggest that vitamin E delays functional deterioration in patients with moderate AD and support the rationale for further clinical trial to verify whether vitamin E could prevent the development of dementia in older individuals with isolated memory loss.
Finally, there is a controversy about possible link between aluminium and AD. Aluminium is a neurotoxicant in animals and humans and some epidemiologic studies have suggested an association between aluminium absorbed with drinking water and dementia, but recent studies have failed to find any relationship (McLachlan et al., 1996; Martyn et al., 1997) . The Paquid cohort, in a 8-year follow-up study, has recently supported the hypothesis that a high concentration of aluminium in drinking water may be a risk factor for AD (Rondeau et al., 2000) . Furthermore, aluminium additives contained in specific widely-available processed foods (i.e. pancakes, biscuits, corn bread, chewing gum, and muffins) may affect the risk of developing AD (Rogers and Simon, 1999) . Finally, recent findings suggest that even with a normal dietary intake, patients with AD had increased absorption of aluminium, supporting the hypothesis that a long-term diet high in acid-forming foods such as proteins leads to increased aluminium absorption even after the diet have changed (Roberts et al., 1998) .
Conclusion
A style of diet based of complex carbohydrates, fibers, cereals, red wine, fresh fruit and vegetables, and nonanimal fat appears to protect against ARCD, and cognitive decline of vascular or degenerative origin. Furthermore, a clear reduction of ARCD risk has been found in a population sample with high intake of MUFA from olive oil. Whether this protective effect of olive oil is attributable exclusively to the high MUFA intake or to the contemporary presence of antioxidants compounds remains to be elucidated. Vitamin deficiencies could also have an effect upon cognitive impairment while foods with large amounts of aluminium-containing additives or aluminium from drinking water may affect the risk of developing AD. At present, healthy diets, antioxidant supplements, and the prevention of nutritional deficiencies in patients with dementia could be considered the first line of defense against the development and progression of cognitive decline.
